Teva trazodone 50 mg tablets recalled for foreign tablets in bottles
Teva Pharmaceuticals discovered that some bottles of trazodone 50 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The issue affects one lot (1394026) with an expiration date of February 2028. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Teva recalls
What to do
- Check your trazodone bottle against lot number 1394026 and expiration date 02/2028.
- If your bottle matches, do not use it and contact your pharmacy or doctor.
- Return the affected bottle to your pharmacy for a replacement.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
- Sold in
- Nationwide
- Made for
- Adults
Details
- Units affected
- 175,392 bottles
- Illnesses reported
- None reported
- Manufactured in
- 400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
- Classification
- Class II
- Recall number
- D-0834-2026
In the FDA's words
- Description
- traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01 Presence of Foreign Tablets/Capsules Lot: 1394026, Exp. 02/2028. Distribution: U.S. Nationwide Affected quantity: 175,392 bottles
- Hazard
- Presence of Foreign Tablets/Capsules
More from Teva
See all- Teva Metoclopramide 5 mg tablets recalled for foreign tablets or capsules in bottles
ModerateFDAOct 21, 2026